|
|
Article: Research Update.
- Article from:
- PR Newswire
- Article date:
- June 7, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New Long-Term Safety and Efficacy Data On EXUBERA(R) (Human Insulin Powder)
Presented at American Diabetes Association Scientific Sessions
ORLANDO, Fla., June 7 -- Results of long-term studies showed sustained
glycemic control and pulmonary function in patients with type 2 diabetes taking
EXUBERA(R), an inhalable, rapid-acting dry powder insulin.(1,2) These new data
were presented this weekend at the 64th Annual Scientific Sessions of the
American Diabetes Association.
A pooled analysis of two one-year open-label studies involving 627
patients with type 2 diabetes showed that patients who added EXUBERA(R) to
their treatment regimen experienced no ...